Oftaquix (Levofloxacin Hemihydrate)

Levofloxacin Hemihydrate, the active ingredient in Oftaquix, is a fluoroquinolone antibiotic presented as a tablet for oral use. It treats a variety of bacterial infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Oftaquix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oftaquix is a fluoroquinolone antibiotic that targets bacterial DNA replication pathways. It is employed in several clinically recognised indications: - Acute bacterial sinusitis: helps shorten the duration of symptoms and eradicates the causative pathogens. - Community‑acquired bacterial pneumonia: provides coverage against typical and atypical respiratory pathogens. - Uncomplicated urinary tract infection: eliminates uropathogens and resolves urinary symptoms. - Skin and soft‑tissue infections: treats susceptible Gram‑negative and Gram‑positive bacteria. - Chronic bronchitis exacerbations: reduces bacterial load and improves airflow obstruction.

Levofloxacin, like other fluoroquinolones, may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, occasionally watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Photosensitivity: increased skin sensitivity to sunlight.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or swelling, especially in the Achilles. - QT prolongation: irregular heart rhythm detectable on ECG. - Severe allergic reaction: rash, swelling, or breathing difficulty. - Central nervous system effects: seizures or severe confusion. - Clostridioides difficile infection: persistent diarrhea after therapy.

When using Levofloxacin, clinicians should consider several safety measures: - Renal impairment: adjust dose based on creatinine clearance. - History of tendon disorders: avoid use in patients with prior tendon injury. - Cardiac risk: monitor QT interval in patients with known arrhythmias. - Pregnancy and lactation: use only if benefits outweigh risks. - Concomitant CNS active drugs: watch for enhanced CNS stimulation. Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Levofloxacin can interact with a variety of medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect and bleeding risk. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heighten risk of CNS stimulation.

Moderate Interactions (Monitor Closely): - Theophylline: may raise serum theophylline concentrations. - Cyclosporine: increased risk of nephrotoxicity. - Oral hypoglycemics: potential for altered blood glucose control.